Systematix Corporate Services , a leading financial services firm, has reported strong financial performance for the second quarter of fiscal year 2026, with significant growth in revenue and profitability. The company has also made strategic moves in its asset management business.

Financial Highlights

• Total income from operations reached Rs 55.72 crore in Q2FY26, marking a 52% year-on-year increase from Rs 36.67 crore in Q2FY25.
• For H1FY26, total income grew by 35% to Rs 89.07 crore, compared to Rs 65.94 crore in H1FY25.
• Profit after tax (PAT) rose to Rs 14.48 crore in Q2FY26 from Rs 10.46 crore in the previous quarter.
• The company's net worth stood at Rs 323.42 crore, with an annualized return on equity (ROE) of 16%.

Launch of India SME Growth Fund

In a significant development for its asset management business, Systematix Corporate Services launched the India SME Growth Fund in August 2025. Key details of the fund include:

• Fund size: Rs 125 crore
• First closure: Achieved in September 2025 with Rs 15 crore commitment received
• Focus: High-growth SMEs across sectors including manufacturing, services, pharma, tech, consumer, defence, chemical, and engineering
• Investor portfolio:

Investment Banking Pipeline

The company reported a robust pipeline of transactions worth Rs 5,300 crore, including 21 IPOs. This strong pipeline indicates potential growth in the investment banking segment.

Leadership Appointments

Systematix Corporate Services has strengthened its private wealth business with two key appointments:

1. Partha Sengupta - Joint Managing Director & CEO for Private Wealth Business
2. Bhaskar Hazra - Joint Managing Director & CEO for Private Wealth Business

Both executives bring extensive experience in banking and wealth management, which is expected to drive the company's growth in the private wealth segment.

Long-Term Growth Trajectory

Over the past four years, Systematix Corporate Services has demonstrated impressive growth:

• Revenue CAGR: 61%
• Profit CAGR: 98%
• Net worth CAGR: 74%
• ROE improvement to 15%

Outlook

The strong financial performance, launch of the new SME fund, robust investment banking pipeline, and strategic leadership appointments position Systematix Corporate Services for continued growth in the financial services sector. The company's focus on diversifying its revenue streams across investment banking, asset management, and private wealth management appears to be yielding positive results.

Investors and market observers will likely keep a close watch on how Systematix Corporate Services leverages its current momentum to capture opportunities in India's evolving financial services landscape.

Systematix Corporate Services Limited has released its monitoring agency report for the quarter ended September 30, 2025, detailing the utilization of funds from its preferential issue worth Rs 103.12 crore. The report, prepared by CARE Ratings Limited, provides insights into the company's progress in deploying the raised capital.

Key Highlights

• Total Utilization: Out of the Rs 103.12 crore raised, the company has utilized Rs 26.50 crore as of September 30, 2025.

• Investment in Subsidiary: Rs 25.00 crore has been invested in Systematix Shares and Stocks (India) Limited, a subsidiary, for working capital requirements.

• AIF Investment: Rs 1.50 crore has been contributed to India SME Growth Fund - Series 2, a Category I Alternative Investment Fund. Systematix Corporate Services Limited will serve as the Sponsor to this scheme.

• Unutilized Funds: The remaining Rs 76.62 crore of unutilized funds have been primarily deployed in fixed deposits with Yes Bank, earning interest rates between 4.75% to 6.95%.

Breakdown of Fund Utilization

Additional Notes

• The company has received SEBI registration for a Category 2 AIF (Registration Number IN/AIF2/25-26/1921), but approval for the scheme launch is still pending.

• There have been no deviations from the stated objectives, and the utilization is in line with the offer document.

• The preferential issue was conducted from October 1, 2024, to December 31, 2024.

• The monitoring agency, CARE Ratings Limited, has reported no deviation from stated objectives and confirmed that all utilization is as per the offer document.

The company has until November 12, 2026, to complete the utilization of funds as per the timelines mentioned in the offer document. As of now, there are no reported delays in the implementation of the stated objectives.

Investors and stakeholders can view this report as an indication of Systematix Corporate Services Limited's progress in deploying the raised capital towards its stated goals, with a significant portion still to be utilized in the coming quarters.